Rafferty Asset Management, LLC Jazz Pharmaceuticals PLC Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 5,457 shares of JAZZ stock, worth $670,065. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,457

Previous 5,131 6.35%

Holding current value

$670,065

Previous $547,000 11.15%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.57 - $116.37 $32,785 - $37,936	326 Added 6.35%	5,457 $608,000
Q2 2024 Aug 13, 2024	BUY	$103.94 - $118.98 $84,711 - $96,968	815 Added 18.88%	5,131 $547,000
Q1 2024 May 13, 2024	BUY	$115.19 - $132.77 $105,283 - $121,351	914 Added 26.87%	4,316 $519,000
Q4 2023 Feb 13, 2024	BUY	$114.26 - $136.0 $80,553 - $95,880	705 Added 26.14%	3,402 $418,000
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $20,740 - $24,702	170 Added 6.73%	2,697 $349,000
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $68,722 - $82,556	561 Added 28.54%	2,527 $313,000
Q1 2023 May 11, 2023	SELL	$133.98 - $160.47 $29,743 - $35,624	-222 Reduced 10.15%	1,966 $287,000
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $35,802 - $44,118	276 Added 14.44%	2,188 $348,000
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $3,417 - $4,351	27 Added 1.43%	1,912 $255,000
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $177,978 - $212,005	-1,257 Reduced 40.01%	1,885 $294,000
Q1 2022 May 13, 2022	SELL	$129.64 - $160.7 $567,823 - $703,866	-4,380 Reduced 58.23%	3,142 $489,000
Q4 2021 Feb 10, 2022	BUY	$119.87 - $145.67 $219,242 - $266,430	1,829 Added 32.13%	7,522 $958,000
Q3 2021 Nov 10, 2021	SELL	$128.64 - $184.79 $16,594 - $23,837	-129 Reduced 2.22%	5,693 $741,000
Q2 2021 Aug 10, 2021	BUY	$160.2 - $186.42 $47,579 - $55,366	297 Added 5.38%	5,822 $1.03 Million
Q1 2021 May 10, 2021	SELL	$150.19 - $173.5 $34,994 - $40,425	-233 Reduced 4.05%	5,525 $908,000
Q4 2020 Feb 10, 2021	BUY	$140.71 - $165.05 $57,691 - $67,670	410 Added 7.67%	5,758 $950,000
Q3 2020 Nov 13, 2020	BUY	$105.46 - $144.13 $257,427 - $351,821	2,441 Added 83.97%	5,348 $763,000
Q2 2020 Aug 07, 2020	BUY	$95.68 - $121.88 $278,141 - $354,305	2,907 New	2,907 $321,000
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $1.02 Million - $1.78 Million	-11,630 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$117.65 - $153.73 $903,787 - $1.18 Million	7,682 Added 194.58%	11,630 $1.74 Million
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $231,207 - $264,564	1,847 Added 87.91%	3,948 $506,000
Q2 2019 Aug 09, 2019	BUY	$125.55 - $144.48 $263,780 - $303,552	2,101 New	2,101 $300,000

Others Institutions Holding JAZZ

# of Institutions

513

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.7B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Jazz Pharmaceuticals PLC Transaction History